摘要
目的:评价海口地区医院降血脂药的应用情况及趋势。方法:对海口地区2家医院2007~2009年降血脂药的销售金额、用药频度、日均费用等进行回顾性统计、分析。结果:该地区2家医院降血脂药的销售金额逐年上升,2008年比2007年增长41.25%,2009年比2008年增长28.96%,主要药品是阿托伐他汀、普伐他汀、氟伐他汀、辛伐他汀、苯扎贝特;销售金额排序与用药频度排序列第1位的每年都是阿托伐他汀。结论:他汀类降血脂药在海口地区降血脂药市场中居于首位,其市场前景看好。
OBJECTIVE:To evaluate the utilization of blood lipid-lowering drugs in Haikou area.METHODS:The consumption sum,DDDs and DDC of blood lipid-lowering drugs in 2 hospitals of Haikou area from 2007 to 2009 were analyzed retrospectively.RESULTS:The consumption sum of blood lipid-lowering drugs in Haikou area increased year by year,up by 41.25% in 2008 than in 2007 and 28.96% in 2009 than in 2008.Blood lipid-lowering drugs were mainly atorvastatin,pravastatin,fluvastatin,simvastatin,bezafibrate.Atorvastatin took up the first place of the list of consumption sum and DDDs in past 3 years.CONCLUSION:Statins occupy the predominate place among blood lipid-lowering drugs and show potential in the market.
出处
《中国药房》
CAS
CSCD
北大核心
2010年第30期2802-2804,共3页
China Pharmacy
关键词
降血脂药
用药频度
日均费用
用药分析
Blood lipid-lowering drugs
DDDs
DDC
Analysis of drug use